Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex - PubMed (original) (raw)
Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex
Frank Barletta et al. Mol Endocrinol. 2002 Feb.
Abstract
When UMR-106 osteoblastic cells, LLCPK1 kidney cells, and VDR transfected COS-7 cells were transfected with the rat 24-hydroxylase [24(OH)ase] promoter (-1,367/+74) or the mouse osteopontin (OPN) promoter (-777/+79), we found that the response to 1,25dihydroxyvitamin D(3) [1,25-(OH)(2)D(3)] could be significantly enhanced 2- to 5-fold by the protein phosphatase inhibitor, okadaic acid (OA). Enhancement of 1,25-(OH)(2)D(3)-induced transcription by OA was also observed using a synthetic reporter gene containing either the proximal 24(OH)ase vitamin D response element (VDRE) or the OPN VDRE, suggesting that the VDRE is sufficient to mediate this effect. OA also enhanced the 1,25-(OH)(2)D(3)-induced levels of 24(OH)ase and OPN mRNA in UMR osteoblastic cells. The effect of OA was not due to an up-regulation of VDR or to an increase in VDR-RXR interaction with the VDRE. To determine whether phosphorylation regulates VDR-mediated transcription by modulating interactions with protein partners, we examined the effect of phosphorylation on the protein-protein interaction between VDR and DRIP205, a subunit of the vitamin D receptor-interacting protein (DRIP) coactivator complex, using glutathione-S-transferase pull-down assays. Similar to the functional studies, OA treatment was consistently found to enhance the interaction of VDR with DRIP205 3- to 4-fold above the interaction observed in the presence of 1,25-(OH)(2)D(3) alone. In addition, studies were done with the activation function-2 defective VDR mutant, L417S, which is unable to stimulate transcription in response to 1,25-(OH)(2)D(3) or to interact with DRIP205. However, in the presence of OA, the mutant VDR was able to activate 24(OH)ase and OPN transcription and to recruit DRIP205, suggesting that OA treatment may result in a conformational change in the activation function-2 defective mutant that creates an active interaction surface with DRIP205. Taken together, these findings suggest that increased interaction between VDR and coactivators such as DRIP205 may be a major mechanism that couples extracellular signals to vitamin D action.
Similar articles
- Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
Liu Y, Shen Q, Malloy PJ, Soliman E, Peng X, Kim S, Pike JW, Feldman D, Christakos S. Liu Y, et al. J Bone Miner Res. 2005 Sep;20(9):1680-91. doi: 10.1359/JBMR.050410. Epub 2005 Apr 27. J Bone Miner Res. 2005. PMID: 16059639 - Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M, Freedman LP, Li H, Christakos S. Raval-Pandya M, et al. Mol Endocrinol. 1998 Sep;12(9):1367-79. doi: 10.1210/mend.12.9.0165. Mol Endocrinol. 1998. PMID: 9731705 - The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK. Haussler MR, et al. J Endocrinol. 1997 Sep;154 Suppl:S57-73. J Endocrinol. 1997. PMID: 9379138 Review. - New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK. Haussler MR, et al. Bone. 1995 Aug;17(2 Suppl):33S-38S. doi: 10.1016/8756-3282(95)00205-r. Bone. 1995. PMID: 8579895 Review.
Cited by
- PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond.
Portales-Castillo I, Simic P. Portales-Castillo I, et al. Front Endocrinol (Lausanne). 2022 Sep 29;13:992666. doi: 10.3389/fendo.2022.992666. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36246903 Free PMC article. Review. - The potential role of circRNA_004229 in hair/epidermal regulation after MED1 ablation in keratinocytes.
Guo P, Huang J, Zhang J, Meng C, Zhang S, Bai Y, Ning Z, Hu L. Guo P, et al. RSC Adv. 2019 Jun 18;9(33):19095-19103. doi: 10.1039/c9ra02322d. eCollection 2019 Jun 14. RSC Adv. 2019. PMID: 35516890 Free PMC article. - Role of Neural Stem Cells and Vitamin D Receptor (VDR)-Mediated Cellular Signaling in the Mitigation of Neurological Diseases.
Uthaiah CA, Beeraka NM, Rajalakshmi R, Ramya CM, Madhunapantula SV. Uthaiah CA, et al. Mol Neurobiol. 2022 Jul;59(7):4065-4105. doi: 10.1007/s12035-022-02837-z. Epub 2022 Apr 27. Mol Neurobiol. 2022. PMID: 35476289 Review. - Pomegranate derivative urolithin A enhances vitamin D receptor signaling to amplify serotonin-related gene induction by 1,25-dihydroxyvitamin D.
Livingston S, Mallick S, Lucas DA, Sabir MS, Sabir ZL, Purdin H, Nidamanuri S, Haussler CA, Haussler MR, Jurutka PW. Livingston S, et al. Biochem Biophys Rep. 2020 Oct 13;24:100825. doi: 10.1016/j.bbrep.2020.100825. eCollection 2020 Dec. Biochem Biophys Rep. 2020. PMID: 33088927 Free PMC article. - Molecular determinants of MED1 interaction with the DNA bound VDR-RXR heterodimer.
Belorusova AY, Bourguet M, Hessmann S, Chalhoub S, Kieffer B, Cianférani S, Rochel N. Belorusova AY, et al. Nucleic Acids Res. 2020 Nov 4;48(19):11199-11213. doi: 10.1093/nar/gkaa775. Nucleic Acids Res. 2020. PMID: 32990725 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous